Charles Theuer
Chief Executive Officer at TRACON PHARMACEUTICALS, INC.
Net worth: 803 641 $ as of 2024-04-29
Charles Theuer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Director/Board Member | 2006-06-30 | - |
| Chief Executive Officer | 2006-08-01 | - | |
| Investor Relations Contact | 2006-06-30 | - | |
| President | 2006-08-01 | - | |
| Comptroller/Controller/Auditor | 2018-06-14 | 2019-09-17 | |
| Director of Finance/CFO | 2018-06-14 | 2021-01-28 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Director/Board Member | 2015-12-31 | - |
| Independent Dir/Board Member | 2015-12-31 | - | |
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 2018-04-30 | - |
| Independent Dir/Board Member | 2018-04-30 | - |
Career history of Charles Theuer
Former positions of Charles Theuer
| Companies | Position | Start | End |
|---|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2003-12-31 | 2005-12-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2002-12-31 | 2003-12-31 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 1990-12-31 | 1992-12-31 |
| University of California, Irvine | Corporate Officer/Principal | - | - |
Training of Charles Theuer
| The University of California, San Francisco | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistics
International
| United States | 10 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Stock Market
- Insiders
- Charles Theuer
- Experience